Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Nephrology | Urology
Disease Category: Nocturia
Location: United States, CA

Clinical Trial Details

Overview

Research Study Summary

Treatment of Nocturia or Frequent Nighttime Urination

Purpose

Phase III Randomized, Double-Blind, Placebo Control, Multicenter Study to Investigate the Efficacy and Safety of SER 120 Nasal Spray Formulation in Patients with Nocturia

Patient Inclusion Criteria:

  • Men and women 50 years of age or older
  • Nocturia 2 or more times per night
  • Normal triglyceride levels

Patient Exclusion Criteria:

  • Incontinence
  • Diabetes
  • Congestive Heart Failure
  • Uncontrolled hypertension
  • History of bladder surgery or radiotherapy
  • Systemic steroids
  • Urological malignancies or unexplained pelvic masses
  • Current urinary tract infection
  • Bladder stones, bladder pain syndrome, interstitial cystitis
  • Obstructive sleep apnea
  • Restless leg syndrome
  • Substance abuse
  • Blood donation within 90 days
  • Smoking
  • Hepatitis, HIV
  • Investigational drug within 30 days
  • Allergic rhinitis or use of intra-nasal medication

To Learn more
Phase

3

Gender

Both Male and Female

Age

50 and up

Overall Status

Recruiting

Facility Type

N/A

Contact

West Coast Clinical Research
5525 Etiwanda Ave., Suite 202
Tarzana, CA 91356
Phone: 818-776-0820, Ext. 101
Fax: 818-776-1269

View Map

Research Center Information: West Coast Clinical Research

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 156461

Date Last Changed: July 24, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.